Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.01. | Foxtons Group - Market share gains in Sales continues apace | 317 | Edison Investment Research | Foxtons Group's FY24 trading update confirmed revenue and adjusted operating profit growth of c 11% and c 33%, respectively, reflecting the developing success of the company's strategic vision. This... ► Artikel lesen | |
28.01. | Information Services Corporation (ISC: TSX) - Management guidance for FY25 | 336 | Edison Investment Research | Information Services Corporation (ISC: TSX) announced its management guidance for FY25, with revenue of C$257-267m and adjusted EBITDA of C$89m-97m (FY24 guidance: revenue of C$240m-250m, adjusted EBITDA... ► Artikel lesen | |
28.01. | Information Services Corporation (ISV: TSX) - Management guidance for FY25 | 303 | Edison Investment Research | Information Services Corporation (ISV: TSX) announced its management guidance for FY25, with revenue of C$257-267m and adjusted EBITDA of C$89m-97m (FY24 guidance: revenue of C$240m-250m, adjusted EBITDA... ► Artikel lesen | |
28.01. | CQS Natural Resources Growth and Income - A natural resources specialist worth preserving | 291 | Edison Investment Research | CQS Natural Resources Growth and Income (CYN) is a differentiated closed-end investment company seeking opportunities across small- and mid-cap mining and resource stocks, which in our view deserves... ► Artikel lesen | |
28.01. | Invesco Asia Trust - A patient Asian champion | 256 | Edison Investment Research | Invesco Asia Trust (IAT) delivered a 12.4% NAV total return (TR) over the 12 months to end-December 2024, bolstered by the stock market rally in China and Hong Kong (to which IAT's managers patiently... ► Artikel lesen | |
28.01. | Lords Group Trading (LSE: LORD) - FY24 trading update points to positive outlook | 292 | Edison Investment Research | As a result of a tough trading environment, Lords Group Trading expects FY24 revenue to be £436m (FY23: £463m) and EBITDA to be 'slightly' below expectations. The merchanting business was down 3.6%... ► Artikel lesen | |
28.01. | Basilea Pharmaceutica (SIX: BSLN) banks another CHF2.2m milestone | 370 | Edison Investment Research | Basilea Pharmaceutica has recorded another CHF2.2m in milestone payments triggered by both commercial anti-infective products, Cresemba and Zevtera, hitting sales thresholds in specific geographies... ► Artikel lesen | |
28.01. | Basilea (SIX: BSLN) banks another CHF2.2m milestone | 475 | Edison Investment Research | Basilea has recorded another CHF2.2m in milestone payments triggered by both commercial anti-infective products, Cresemba and Zevtera, hitting sales thresholds in specific geographies in 2024. This... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 2.593 |
EVOTEC | 2.177 |
NOVO NORDISK | 1.656 |
RHEINMETALL | 1.087 |
TESLA | 1.031 |
RENK GROUP | 1.028 |
BYD | 828 |
TUI | 810 |
DEUTZ | 794 |
STEYR MOTORS | 785 |
SIEMENS ENERGY | 692 |
UNITEDHEALTH | 620 |
PLUG POWER | 583 |
NEL | 566 |
APPLE | 505 |
VOLKSWAGEN | 483 |
PUMA | 482 |
BASF | 447 |
ALMONTY | 439 |
ELI LILLY | 424 |
DEUTSCHE BANK | 422 |
BAYER | 420 |
MERCEDES-BENZ | 401 |
TSMC | 396 |
XIAOMI | 384 |